139 related articles for article (PubMed ID: 32235863)
1. High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4.
Lin GY; Lin L; Cai XQ; Dai AT; Zhu Y; Li J; Liu Q; Yang DH; Bathgate RAD; Wang MW
Acta Pharmacol Sin; 2020 Oct; 41(10):1328-1336. PubMed ID: 32235863
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist.
Lin G; Feng Y; Cai X; Zhou C; Shao L; Chen Y; Chen L; Liu Q; Zhou Q; Bathgate RAD; Yang D; Wang MW
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946593
[TBL] [Abstract][Full Text] [Related]
3. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
4. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4.
Praveen P; Bathgate RAD; Hossain MA
Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
7. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists.
Lin L; Lin G; Zhou Q; Bathgate RAD; Gong GQ; Yang D; Liu Q; Wang MW
Bioorg Chem; 2021 May; 110():104782. PubMed ID: 33730669
[TBL] [Abstract][Full Text] [Related]
9. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
10. The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity.
Patil NA; Bathgate RAD; Kocan M; Ang SY; Tailhades J; Separovic F; Summers R; Grosse J; Hughes RA; Wade JD; Hossain MA
Amino Acids; 2016 Apr; 48(4):987-992. PubMed ID: 26661035
[TBL] [Abstract][Full Text] [Related]
11. Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4.
Wu H; Handley TNG; Hoare BL; Hartono HA; Scott DJ; Chalmers DK; Bathgate RAD; Hossain MA
Biochem Pharmacol; 2024 Jun; 224():116239. PubMed ID: 38679208
[TBL] [Abstract][Full Text] [Related]
12. Colokinetic effect of an insulin-like peptide 5-related agonist of the RXFP4 receptor.
Diwakarla S; Bathgate RAD; Zhang X; Hossain MA; Furness JB
Neurogastroenterol Motil; 2020 May; 32(5):e13796. PubMed ID: 31989750
[TBL] [Abstract][Full Text] [Related]
13. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
14. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
15. Expression of the relaxin family peptide 4 receptor by enterochromaffin cells of the mouse large intestine.
Koo A; Pustovit RV; Woodward ORM; Lewis JE; Gribble FM; Hossain MA; Reimann F; Furness JB
Cell Tissue Res; 2022 Jul; 389(1):1-9. PubMed ID: 35596811
[TBL] [Abstract][Full Text] [Related]
16. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
17. Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4.
Hu MJ; Wei D; Shao XX; Wang JH; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2017 Apr; 619():27-34. PubMed ID: 28274616
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of relaxin family peptide receptor 4 in human spermatozoa and impact of insulin-like peptide 5 on sperm functions.
Yeganeh IS; Taromchi AH; Fathabadi FF; Nejatbakhsh R; Novin MG; Shokri S
Reprod Biol; 2017 Dec; 17(4):327-332. PubMed ID: 28986276
[TBL] [Abstract][Full Text] [Related]
19. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
[TBL] [Abstract][Full Text] [Related]
20. Reviewing the physiological roles of the novel hormone-receptor pair INSL5-RXFP4: a protective energy sensor?
Hechter D; Vahkal B; Tiede T; Good SV
J Mol Endocrinol; 2022 May; 69(1):R45-R62. PubMed ID: 35521762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
